| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/02/2011 | EP2289547A1 Vaccine for treatment and prevention of herpes simplex virus infection |
| 03/02/2011 | EP2289546A2 Injectable vaccines against multiple meningococcal serogroups |
| 03/02/2011 | EP2289545A2 Supplemented OMV vaccine against meningococcus |
| 03/02/2011 | EP2289544A2 Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| 03/02/2011 | EP2289543A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody |
| 03/02/2011 | EP2289542A1 Treatment of neurological or neurodegenerative disorders |
| 03/02/2011 | EP2289534A1 Modulation of NKG2D |
| 03/02/2011 | EP2289516A1 Methods and means for the treatment of HPV induced intraepithelial neoplasias |
| 03/02/2011 | EP2289513A2 Method for decreasing the blood glucose level in mammals |
| 03/02/2011 | EP2288717A1 Monoclonal antibodies to basic fibroblast growth factor |
| 03/02/2011 | EP2288702A1 Combination therapies against cancer |
| 03/02/2011 | EP2288693A1 Novel astrovirus |
| 03/02/2011 | EP2288623A2 Method of generating single vl domain antibodies in transgenic animals |
| 03/02/2011 | EP2288619A2 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
| 03/02/2011 | EP2288384A2 Treatment of thromboangiitis obliterans by removal of autoantibodies |
| 03/02/2011 | EP2288383A1 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer |
| 03/02/2011 | EP2288382A2 Anti- il-17a/il-17f cross-reactive antibodies and methods of use thereof |
| 03/02/2011 | EP2288381A2 Products and methods for stimulating an immune response |
| 03/02/2011 | EP2288380A2 Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same |
| 03/02/2011 | EP2288379A2 Dual delivery system for heterologous antigens |
| 03/02/2011 | EP2288359A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 03/02/2011 | EP1814386B1 Methods of studying tolerance in mhc-ii transgenic animals |
| 03/02/2011 | EP1725871B1 Separation of unconjugated and conjugated saccharides by solid phase extraction |
| 03/02/2011 | EP1673633B9 Method for detecting feline immunodeficiency virus |
| 03/02/2011 | EP1650225B1 Hetero type pentamer recombinant vaccine |
| 03/02/2011 | EP1646656B1 Human antibody molecules for il-13 |
| 03/02/2011 | EP1513934B1 Genes and polypeptides relating to human colon cancers |
| 03/02/2011 | EP1495056B1 Methods of analyzing antibody disulfide isomers |
| 03/02/2011 | EP1456390B1 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 03/02/2011 | EP1368456B1 Anti-bacterial vaccine compositions |
| 03/02/2011 | EP1363663B1 Nucleic acid mucosal immunization |
| 03/02/2011 | EP1185662B1 Dna vaccines for dogs |
| 03/02/2011 | CN1832965B Endothelial cell specific antibodies and uses thereof |
| 03/02/2011 | CN1714150B Genetic products differentially expressed in tumors and the use thereof |
| 03/02/2011 | CN1674935B Biofunctional composition containing CpG or oligo-/polynucleotide and toxin or enterotoxin |
| 03/02/2011 | CN1646157B Multiple and multivalent DNA vaccines in ovo |
| 03/02/2011 | CN101983208A 胰高血糖素受体拮抗剂 Glucagon receptor antagonists |
| 03/02/2011 | CN101983207A Anti mif antibodies |
| 03/02/2011 | CN101983071A Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-hodgkin' s lymphomas |
| 03/02/2011 | CN101983070A Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells |
| 03/02/2011 | CN101983069A Influenza hemagglutinin and neuraminidase variants |
| 03/02/2011 | CN101983063A Anti-infective agents and uses thereof |
| 03/01/2011 | US7897740 Secreted protein called 36P6D5 characteristic of tumors |
| 03/01/2011 | US7897730 TRAIL receptor-binding agents and uses of the same |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897380 Circular nucleic acid vectors, and methods for making and using the same |
| 03/01/2011 | US7897355 Expression vector comprising nucleotide sequences coding novel gene which is expressed in prostate tissues for use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897343 Propagating attenuated lelystad agent in host cells for use in generating vaccine for prevention and treatment of procine respiratory infection |
| 03/01/2011 | US7897332 Immunoglobulin for detecting lymphadenopathy associated viral infections; immunodiagnostics |
| 03/01/2011 | US7897159 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
| 03/01/2011 | US7897158 Recombinant toxin fragments |
| 03/01/2011 | US7897156 Modified vaccinia virus ankara for the vaccination of neonates |
| 03/01/2011 | US7897155 Method for producing yeast expressed HPV types 6 and 16 capsid proteins |
| 03/01/2011 | US7897153 Chimera of human IgE receptor α-chain and avian constant immuno-globulin domains for the determination of serum IgE |
| 03/01/2011 | US7897152 Viral chemokine-antigen fusion proteins |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | US7897150 Canine lymphoma cell line and uses thereof |
| 03/01/2011 | US7897149 Fully human anti-VAP-1 monoclonal antibodies |
| 03/01/2011 | US7897148 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
| 03/01/2011 | US7897146 Treatment using herpes simplex virus |
| 03/01/2011 | US7897139 PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 03/01/2011 | CA2342203C Method for removal of hiv and other viruses from blood |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 03/01/2011 | CA2301709C Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 03/01/2011 | CA2217820C Milk and milk products for preventing or treating heart disease |
| 02/24/2011 | WO2011022727A2 Antibodies against the ectodomain of erbb3 and uses thereof |
| 02/24/2011 | WO2011022725A2 Mimotopes of hiv and uses thereof |
| 02/24/2011 | WO2011022710A1 Therapeutic methods and compositions |
| 02/24/2011 | WO2011022656A2 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 02/24/2011 | WO2011022617A1 Methods for diagnosing diabetes and determining effectiveness of treatments |
| 02/24/2011 | WO2011022522A1 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| 02/24/2011 | WO2011022472A2 Methods and compositions for the treatment of proliferative and pathogenic diseases |
| 02/24/2011 | WO2011022462A2 Neural regeneration |
| 02/24/2011 | WO2011022394A2 Materials and methods for the development of an antigen-specific immune non-responsiveness state |
| 02/24/2011 | WO2011022339A1 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents |
| 02/24/2011 | WO2011022334A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
| 02/24/2011 | WO2011022264A1 Anti-angiogenesis therapy for the treatment of previously treated breast cancer |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011022002A1 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| 02/24/2011 | WO2011021381A1 Pharmaceutical composition containing anti-hb-egf antibody as active ingredient |
| 02/24/2011 | WO2011020874A1 Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy |
| 02/24/2011 | WO2011020604A1 Multiepitope vaccine for her2/neu-associated cancers |
| 02/24/2011 | WO2011020155A1 Anti p2x7 receptor antibodies and fragments thereof |
| 02/24/2011 | WO2011020133A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
| 02/24/2011 | WO2011005799A3 Rna containing modified nucleotides and use thereof in vaccines |
| 02/24/2011 | WO2011003100A3 Compositions and methods for diagnosing and/or treating influenza infection |
| 02/24/2011 | WO2010149641A3 Pharmaceutical agent |
| 02/24/2011 | WO2010146062A3 Novel anti-nematode therapies targetting strm-1 |
| 02/24/2011 | WO2010136508A3 Stem cell targeting |
| 02/24/2011 | WO2010136492A3 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye. |
| 02/24/2011 | WO2010135704A3 Secretion-related bacterial proteins for nlrc4 stimulation |
| 02/24/2011 | WO2010132764A3 Live-attenuated compositions for bacterial infections |
| 02/24/2011 | WO2010115172A3 Antigenic peptide of hsv-2 and methods for using same |
| 02/24/2011 | WO2010107909A3 Methods and compositions for the detection of cancer |
| 02/24/2011 | WO2010104749A3 Antigen presenting cell targeted cancer vaccines |